Raul Cordoba, Associate Chief at the Department of Hematology at Jiménez Díaz Foundation, shared an article on X Julia Wendler and colleagues authored:
“Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma.”
Title: Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma
Authors: Julia Wendler, Richard I. Lewis, Alexandra Kutilina, Markus Knott, Lisa Kristina Isbell, Elke Valk, Peter Borchmann, Jan-Michel Heger, Gerald Illerhaus, Elisabeth Schorb
Journal: Haemotoligica
More posts featuring Raul Cordoba.